期刊名称：ARCHIV DER PHARMAZIE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
 Archiv der Pharmazie - Chemistry in Life Sciences is an international journal devoted to research and development in all fields of pharmaceutical and medicinal chemistry. Emphasis is put on papers combining synthetic organic chemistry, structural biology, molecular modelling, bioorganic chemistry, natural products chemistry, biochemistry or analytical methods with pharmaceutical or medicinal aspects such as biological activity. The focus of this journal is put on original research papers, but other scientifically valuable contributions (e.g. reviews, minireviews, highlights, symposia contributions, discussions, and essays) are also welcome.
Instructions to Authors
Instructions to Authors
1 General
The submitting author vouches that the work has not
been published elsewhere, either completely, in part, or
in any other form and that the manuscript has not been
submitted to another journal. The submitting author
(listed under 揅orrespondence? accepts the responsibility
of having included as co-authors all persons appropriate
and none inappropriate. The submitting author certifies
that all co-authors have seen a draft copy of the
manuscript and agree with its publication.
Archiv der Pharmazie ?Chemistry in Life Sciences offers a
web-based manuscript submission and peer review system
at http://mc.manuscriptcentral.com/archpharm.
This service guarantees fast and safe submission of manuscripts
and a rapid assessment process.
Usage of this system is obligatory, exceptions can only be
made in fully justified cases.
To submit your manuscript online, please proceed along
the following steps:
* Prepare your manuscript and illustrations in the
appropriate format, according to the instructions
given below (see Sections 3 to 6). Please also make
sure that your paper conforms to the scientific and
style instructions of Archiv der Pharmazie ?Chemistry
in Life Sciences as given herein. You can also find a
link to these instructions at the submission site on
the homepage of the journal at http://www.arch
pharm.de under the link 揊or Authors?
* If you have not already done so, create an account for
yourself in the system at the submission site http://
mc.manuscriptcentral.com/archpharm by clicking
on the 揅reate an Account?button. To monitor the
progress of your manuscript throughout the review
process, just login periodically and check your
Author Center.
* Please be sure to study the 揑nstructions and Forms?BR>given on the Archiv der Pharmazie ?Chemistry in Life
Sciences homepage carefully, and then let the system
guide you through the submission process.
Online help is available to you at all times during the
process. You are also able to exit/re-enter at any stage
before finally 搒ubmitting?your work. All submissions
are kept strictly confidential. If you have any
questions concerning the online submission program,
do not hesitate to contact the editorial support
at archpharm@wiley-vch.de.
* If the contribution contains one or more color figures
the author is also required to submit the 揅olor
Figures Order Form?to the Editorial Office. This form
can be found directly on the homepage of the journal
at http://www.archpharm.de under the link 揊or
Authors? see also 4.1.10.
Archiv der Pharmazie ?Chemistry in Life Sciences
Prof. Dr. Holger Stark,
Editor-in-Chief
Johann Wolfgang Goethe-Universitt
Institut fr Pharmazeutische Chemie
Biozentrum
Marie-Curie-Strasse 9
60439 Frankfurt am Main, Germany
E-mail: h.stark@pharmchem.uni-frankfurt.de
Phone: +49-(0)69 798 29302
Fax: +49-(0)69 798 29258
* Manuscripts files should have margins of 2 cm and
be 1.5-line spaced. Please avoid Far-Eastern symbols.
Please number each page of the manuscript consecutively,
starting with the title page.
* Copies of manuscripts to be published or submitted
elsewhere must be included, if their content
impinges on the results in the present manuscript.
* All contributions are subject to refereeing. Authors
may suggest up to four potential referees (give complete
addresses, fax and e-mail numbers). They may
also list individuals who they wish to be excluded
from the review process. The corresponding author
will be immediately informed of acceptance, need for
revision or rejection.
* A revised paper will retain its original date of receipt
only if it is resubmitted within three months after
revision was requested. Responsibility for the factual
accuracy of a paper rests entirely with the author.
* The editorial staff reserves the right to edit the manuscript.
* Before publication the corresponding author receives
galley proofs for the sole purpose of correcting misprints
and/or absolutely necessary corrections. Proofs
will be sent as a zipped pdf file directly by the typesetter.
Corrections must be returned within 48
hours. Checking of proofs is solely the author抯
responsibility.
* After publication of the paper the corresponding
author will receive one complementary copy of the
issue containing his/her article. He/she will be
Arch. Pharm. Chem. Life Sci. 22008, 341, 1? R. Byrne et al. 1
i 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
2 Instructions to Authors Arch. Pharm. Chem. Life Sci. 2008, 341, 1?
invoiced for any additional copies or reprints, which
may be ordered when returning the galley proofs.
* Authors in Japan please note: Wiley-Japan can provide
authors in Japan with a list of recommended services
to check and improve the English of their
papers before submission. For more information
please contact the Wiley-Japan office by e-mail
(wileyjpn@mb.kcom.ne.jp) or fax (+813-3556 9763).
2 Main subjects
Archiv der Pharmazie ?Chemistry in Life Sciences (Arch.
Pharm. Chem. Life Sci.) is an international journal
devoted to research and development in all fields of pharmaceutical
and medicinal chemistry. Emphasis is put on
papers combining synthetic organic chemistry, structural
biology, molecular modelling, bioorganic chemistry,
natural products chemistry, biochemistry or analytical
methods with pharmaceutical or medicinal aspects
such as biological activity. The emphasis of this journal is
put on original research papers, but other scientifically
valuable contributions (e. g. reviews, minireviews, highlights,
symposia contributions, discussions, and essays)
are also welcome.
3 Types of papers
3.1 Research papers
* Research papers consist of experimental and theoretical
work with new results in the topics given in section
2.
* Research papers should not exceed 7 printed pages
(equivalent to a total of 44,000 characters). In addition,
up to 8 figures and tables may be included.
* The manuscript should be organised as follows:
3.1.1 First page
The first page of the manuscript contains the following
items:
* The title of the paper. Titles should be concise, informative
and contain about 12 words. Please capitalise
nouns, verbs and adjectives. Also, please avoid abbreviations.
* The full names (including first name spelled out) of
authors and the name of the institution or company.
If the publication originates from authors of different
affiliations, they should be clearly stated by using
superscript letters.
* A running title not exceeding 55 letters. This title
will be used in the heading line of the printed paper.
* Name and full postal address, including phone, fax
and e-mail numbers, of the author to whom all correspondence
(including galley proofs) should be sent.
* Up to 5 key words, which will be used for compiling
the subject index.
3.1.2 Summary and graphical abstract
Starting with page 2 a summary should be given. The
summary should not exceed 200 words and should give
scientific rationale, results and conclusions of the work
in a concise and informative form. When necessary
explain unofficial abbreviations. The summary should be
written so that it can be directly used for abstract journals
and data banks.
For all manuscripts a short text for the table of contents
of the issue (ca. 450?90 characters) should be included
as the last page of the manuscript. The text should (ideally
with the help of a graphic) arouse curiosity. Repetition
or a paraphrase of the title and presentation of
experimental details should be avoided.
3.1.3 Introduction
The introduction should explain sufficiently but concisely
the latest scientific research on the subject using
recent international references. It should be followed by
a short statement of the works objectives showing why
the work was done.
3.1.4 Results
* The results should be described by tables, figures,
schemes, formulae etc.
* Contents of tables or figures should not be repeated
in the text, but should be elucidated if necessary.
* Experimental data should be evaluated by suitable
statistical methods. Asterisks are reserved to indicate
statistics in tables and figures.
3.1.5 Discussion
* The results should be discussed in relation to present
knowledge and the aim of the work.
* Conclusions should be drawn (e. g., for further
research, possibilities of transfer into practice or production)
if appropriate in a separate section.
* Results and discussion may be combined if appropriate.
3.1.6 Experimental
This section should be written in a manner that enables
the reader to follow in detail and reproduce the experiments.
For materials and equipment the manufacturer抯
name and location (city, country) should be provided. It
is sufficient to cite the corresponding reference for exact
description of a method. An additional short description
i 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.archpharm.com
Arch. Pharm. Chem. Life Sci. 2008, 341, 1? Instructions to Authors 3
is advisable if the references are not easily accessible or
are given in unfamiliar languages.
3.1.7 Acknowledgements
Acknowledgements can be published at the end of the
text after Experimental.
3.1.8 Conflict of Interest
All authors must declare financial/commercial conflicts
of interest. Even if there are none, this should be stated
in a separate paragraph following on from the acknowledgements
section. This is a mandatory requirement for
all articles.
3.1.9 References
Responsibility for accuracy of references rests with the
author(s).
References should be limited in number to those absolutely
necessary. Frequently, collective reference to older
publications can be made by citing a review.
References should be numbered sequentially in the order
cited in the text. Numbers should be enclosed in square
brackets, thus:
搮as was shown by Brown [1], Sturgeon and Senina [2, 3]
and Smith et al. [4?]?
References are collected in numerical order at the end of
the manuscript under the heading 揜eferences? They
should also be typed with 1.5-line spacing and correspond
in detail to the following examples:
* Journal articles
[1] S. L. Bartley, K. R. Dunbar, Angew. Chem. 1991, 103,
447?50.
Titles of journals are abbreviated according to the
practice of Chemical Abstracts.
Allusions to 搖npublished observations? 損aper to
be published? 損aper in preparation?or 搒ubmitted
for publication?and the like should be a part of the
text, in parenthesis. Papers that have been accepted
by a journal and have not yet appeared, may be cited
in the list of references with the journal抯 name followed
by 搃n press? Two copies of this manuscript/
galley proofs must accompany the manuscript sent
to Arch. Pharm. Chem. Life Sci.
* Books
[2] A. A. Antony in The ACS Style Guide (Ed.: J. S. Dodd),
American Chemical Society, Washington, DC, 1986,
chapter 6.
Titles of books should never be abbreviated.
* Theses
[4] R. M. Hopmann, Ph. D. Thesis, Technical University
of Berlin, 1983.
* Patents
[5] C. R. A. Botta (Bayer AG). DBP 2235093. 1973
[Chem. Abstr. 1974, 80, P55356c].
Please note that abstracts of papers published in Arch.
Pharm. Chem. Life Sci. are available free of charge in Wiley
InterScience at http://www3.interscience.wiley.com.
3.1.10 Tables
* Tables should be appended to the manuscript, each
on a separate sheet.
* Tables should consist of the Arabic number of the
table (in order of its mention, the word ,table?should
be capitalised and not abbreviated, i. e. Table 2), an
explanatory headline (following the number of the
table), and the table itself.
* Tables should be divided by 3 horizontal lines, only.
* Units of measurement should be given in square
brackets below or behind the unit indication, respectively,
e. g. Temperature (8C).
* For footnotes please use superscript letters, e. g. in
tablea) ?BR>* Tables must be cited in the text.
3.1.11 Figures and Schemes
* Figures and Schemes should be appended to the
manuscript, each on a separate sheet without legend.
* They should be given in Arabic numbers according to
their appearance in the text. Please indicate the Figure
or Scheme number and first author.
* Figures and schemes should be submitted in a format
which can be reduced to a width of 5--8 cm or
11--17 cm, and symbols and captions to a height of
1.5--2.0 (after reduction). As far as possible, all lettering
should be the same size.
* Figures and schemes should be submitted on separate
pages at the end of the article (new page for each
complete figure and scheme).
* Colour figures can be reproduced. However, we ask
authors to contribute towards the extra costs
incurred for the reproduction of colour with 495 e
per figure.
* All legends should be typed successively on a separate
sheet after References.
* Legends should be self-explanatory and consist of figure
or scheme number, headline and experimental.
* Figures and schemes must be cited in the text.
* Double presentation of data in both figures and
tables must be avoided.
3.1.12 Nomenclature, symbols, units
Use only SI quantities and units (SI = Systme International
d扷nits). All nomenclature should follow established
rules wherever these are available.
i 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.archpharm.com
4 Instructions to Authors Arch. Pharm. Chem. Life Sci. 2008, 341, 1?
3.1.13 Mathematical equations
Mathematical equations should be drawn or written in
the manuscript at the appropriate places where they
belong. They should always stand alone (i. e. occupy extra
lines).
3.2 Short communications
Short communications should contain novel experimental
or theoretical results in need of urgent publication.
Please add the term 揝hort Communication?below the
title. A short communication contains a summary and
should not exceed 4 printed pages (including Tables, Figures
and References). The same manuscript organisation
as described under section 3.1 applies.
3.3 Reviews
Reviews are comprehensive critical descriptions on present
knowledge of actual research subjects or technological
developments. Please add the term 揜eview?below
the title. Section division is left to the author(s), otherwise
criteria of section 3.1 apply. The length of review
articles should not exceed printed 9?0 pages (equivalent
to a total of 60,000 characters). Reviews are frequently
submitted by invitation. They are, of course, also welcome
from other authors.
4 Revised manuscripts
Revised manuscripts should be returned as follows. A
text file in which all alterations are clearly marked and
visible should be submitted. Use either (1) the track
change mode in Word or (2) change the script colour of
areas containing the required alterations. The manuscript
should be accompanied by a point by point letter
summarising how you have dealt with each of the
reviewers?remarks. The file(s) with the changes visible on
screen should be submitted to the online procedure.
Upon acceptance of the manuscript the final uploaded
version will be taken as the basis for copyediting and the
subsequent production process.
5 Guidelines for preparation of electronic
data
All submissions will be converted to PDF format during
the upload process. The system automatically generates
one PDF file which contains all parts of the manuscript.
This file is available at the manuscript site in two versions,
i. e., in reduced as well as in full resolution. Ensure
that data are given in the order and style as outlined
above. The text of the manuscripts should be made out
using Word or rich text format. Please avoid Far-Eastern
symbols as many do not convert properly. The files
should have margins of 2 cm and be 1.5-line spaced.
Please number each page of the manuscript consecutively,
starting with the title page. The ,hyphenation feature?BR>should be switched off; hyphens should only be
used for compound words. Only use carriage returns (E00 )
to end headings and paragraphs; spacing will be introduced
by the typesetter. Do not use the spacebar to make
indents; where these are required (e. g. tables) use the
TAB key.
All figures and schemes have to be supplied in TIF or EPS
format. They should have the following resolution:
Type Resolution
Graphs and schemes 800?200 DPI
Photos 400?800 DPI
Color (only CMYK) 300?400 DPI
6 Final remarks
Authors are cordially requested to follow these instructions.
By doing so, they facilitate the work for themselves,
the editorial staff, and the referees. Thereby avoiding
queries and unnecessary delays. Thank you in advance
for your cooperation.
i
Instructions to Authors
a0365-6233.pdf
Editorial Board
Editor-in-Chief: Prof. Dr. Holger Stark
Johann Wolfgang Goethe-Universit鋞
Institut f黵 Pharmazeutische Chemie
Biozentrum
Marie-Curie-Strasse 9
60439 Frankfurt am Main, Germany
E-mail: h.stark@pharmchem.uni-frankfurt.de
Phone: +49(0)69 798-29302
Fax: +49(0)69 798-29258
Senior Editors: Prof. Dr. Mikiko Sodeoka Saitama, Japan
Prof. Dr. Andreas Link, Greifswald, Germany
Editorial Board: H. Y. Aboul-Enein, Riyadh
B. Clement, Kiel
G. Dannhardt, Mainz
J. Engel, Frankfurt
C. R. Ganellin, London
F. Gualtieri, Firenze
W. Hartwig, Wuppertal
M. Hilbert, Strasbourg
R. F. Hirschmann, Philadelphia
D. H. Kim, Pohang
Y. Kiso, Kyoto
H. Kondo, Osaka
P. Krogsgaard-Larsen, Copenhagen
M. Lang, Basel
A. Matsuda, Sapporo
M. Matsuo, Osaka
C. Melchiorre, Bologna
S. Mobashery, Detroit
H. H. Otto, Greifswald
D. H. Rich, Madison
B. P. Roques, Paris
W. Schunack, Berlin
J. K. Seydel, Borstel
K. Shudo, Tokyo
R. B. Silverman, Evanston
B. Testa, Lausanne
H. Timmerman, Amsterdam
J. P. Tollenaere, Beerse
C. G. Wermuth, Strasbourg
Publisher: Wiley-VCH Verlag GmbH & Co. KGaA
P. O. Box 10 11 61
D-69451 Weinheim
Germany
Phone: +49(0)6201/606-0
Fax: +49(0)6201/606-207
|
刊名字顺( Alphabetical List of Journals):
返回页首 